Skip to main content
. 2022 Mar 16;17(3):e0265427. doi: 10.1371/journal.pone.0265427

Fig 3. Subject with positive 18F-FSPG (SUVmax 3.5) and 18F-FDG (SUVmax 7.4) PET/CT.

Fig 3